Synopsis
Synopsis
0
USDMF
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 10034-99-8
2. Epsom Salt
3. Magnesium Sulphate Heptahydrate
4. Magnesium Sulfate (1:1) Heptahydrate
5. Magnesia Sulphurica
6. Mfcd00149785
7. Magnesium;sulfate;heptahydrate
8. Epsom Salt(heptahydrate)
9. Sulfuric Acid Magnesium Salt (1:1), Heptahydrate
10. Magnesiumsulfateheptahydrate
11. Sk47b8698t
12. Sulfuric Acid Magnesium Salt Heptahydrate
13. Epsomite
14. Magnesium Sulfate [usan:jan]
15. Mgso4*7h2o
16. Mgso4.7h2o
17. Magnesium Sufate Heptahydrate
18. Bittersalz
19. Unii-sk47b8698t
20. Epsomite (mg(so4).7h20)
21. Magnesium Sulfate Heptahydrate (mgso4.7h2o)
22. Sulfuric Acid, Magnesium Salt, Hydrate (1:1:7)
23. Sulfuric Acid, Magnesium Salt (1:1), Heptahydrate
24. Conclyte-mg (tn)
25. Magnesium Sulfate (usp)
26. Magnesium(ii), Sulfate, Heptahydrate
27. Magnesii Sulfatis Heptahydras
28. Magnesium Sulphate 7-hydrate
29. Epsom Salt [who-ip]
30. Chembl3989857
31. Dtxsid5040544
32. Chebi:31795
33. Magnesium Sulfate--water (1/7)
34. Magnesia Sulphurica [hpus]
35. Magnesium Sulfate Hydrate (jp17)
36. Akos015903838
37. Magnesium Sulfate Hydrate [jan]
38. 14457-55-7
39. Magnesium Sulfate Heptahydrate [mi]
40. Ft-0628096
41. E-518(magnesium Sulfate Heptahydrate)
42. Magnesium Sulphate (1:1) Heptahydrate
43. D01108
44. Magnesium Sulfate Heptahydrate [who-dd]
45. Ins-518(magnesium Sulfate Heptahydrate)
46. Ins No.518(magnesium Sulfate Heptahydrate)
47. Magnesii Sulfatis Heptahydras [who-ip Latin]
48. Magnesium Sulfate Heptahydrate [ep Impurity]
49. Magnesium Sulfate Heptahydrate [ep Monograph]
50. Magnesium Sulfate Heptahydrate, Cell Culture Reagent
51. Magnesium Sulfate Heptahydrate [usp Monograph]
52. Q15628528
Molecular Weight | 246.48 g/mol |
---|---|
Molecular Formula | H14MgO11S |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 0 |
Exact Mass | 246.0107241 g/mol |
Monoisotopic Mass | 246.0107241 g/mol |
Topological Polar Surface Area | 95.6 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 62.2 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 9 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
94
PharmaCompass offers a list of Magnesium Sulfate Heptahydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium Sulfate Heptahydrate manufacturer or Magnesium Sulfate Heptahydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium Sulfate Heptahydrate manufacturer or Magnesium Sulfate Heptahydrate supplier.
PharmaCompass also assists you with knowing the Magnesium Sulfate Heptahydrate API Price utilized in the formulation of products. Magnesium Sulfate Heptahydrate API Price is not always fixed or binding as the Magnesium Sulfate Heptahydrate Price is obtained through a variety of data sources. The Magnesium Sulfate Heptahydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A magnesium sulphate heptahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of magnesium sulphate heptahydrate, including repackagers and relabelers. The FDA regulates magnesium sulphate heptahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. magnesium sulphate heptahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of magnesium sulphate heptahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A magnesium sulphate heptahydrate supplier is an individual or a company that provides magnesium sulphate heptahydrate active pharmaceutical ingredient (API) or magnesium sulphate heptahydrate finished formulations upon request. The magnesium sulphate heptahydrate suppliers may include magnesium sulphate heptahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of magnesium sulphate heptahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a magnesium sulphate heptahydrate Drug Master File in Korea (magnesium sulphate heptahydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of magnesium sulphate heptahydrate. The MFDS reviews the magnesium sulphate heptahydrate KDMF as part of the drug registration process and uses the information provided in the magnesium sulphate heptahydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a magnesium sulphate heptahydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their magnesium sulphate heptahydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of magnesium sulphate heptahydrate suppliers with KDMF on PharmaCompass.
A magnesium sulphate heptahydrate CEP of the European Pharmacopoeia monograph is often referred to as a magnesium sulphate heptahydrate Certificate of Suitability (COS). The purpose of a magnesium sulphate heptahydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of magnesium sulphate heptahydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of magnesium sulphate heptahydrate to their clients by showing that a magnesium sulphate heptahydrate CEP has been issued for it. The manufacturer submits a magnesium sulphate heptahydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a magnesium sulphate heptahydrate CEP holder for the record. Additionally, the data presented in the magnesium sulphate heptahydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the magnesium sulphate heptahydrate DMF.
A magnesium sulphate heptahydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. magnesium sulphate heptahydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of magnesium sulphate heptahydrate suppliers with CEP (COS) on PharmaCompass.
A magnesium sulphate heptahydrate written confirmation (magnesium sulphate heptahydrate WC) is an official document issued by a regulatory agency to a magnesium sulphate heptahydrate manufacturer, verifying that the manufacturing facility of a magnesium sulphate heptahydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting magnesium sulphate heptahydrate APIs or magnesium sulphate heptahydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a magnesium sulphate heptahydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of magnesium sulphate heptahydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing magnesium sulphate heptahydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for magnesium sulphate heptahydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture magnesium sulphate heptahydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain magnesium sulphate heptahydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a magnesium sulphate heptahydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of magnesium sulphate heptahydrate suppliers with NDC on PharmaCompass.
magnesium sulphate heptahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of magnesium sulphate heptahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right magnesium sulphate heptahydrate GMP manufacturer or magnesium sulphate heptahydrate GMP API supplier for your needs.
A magnesium sulphate heptahydrate CoA (Certificate of Analysis) is a formal document that attests to magnesium sulphate heptahydrate's compliance with magnesium sulphate heptahydrate specifications and serves as a tool for batch-level quality control.
magnesium sulphate heptahydrate CoA mostly includes findings from lab analyses of a specific batch. For each magnesium sulphate heptahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
magnesium sulphate heptahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (magnesium sulphate heptahydrate EP), magnesium sulphate heptahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (magnesium sulphate heptahydrate USP).